2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction

Maddox, Thomas M., Januzzi, James L., Allen, Larry A., Breathett, Khadijah, Brouse, Sara, Butler, Javed, Davis, Leslie L., Fonarow, Gregg C. +9 more·2024·Journal of the American College of Cardiology
DOI 10.1016/j.jacc.2023.12.024

Cites (255)

Items 201–250 of 250

  1. Remote Patient Monitoring in Heart Failure: Factors for Clinical Efficacy
    Ankit Bhatia, Thomas M. Maddox · 2020 · International Journal of Heart Failure
  2. Financial Toxicity of Medical Management of Heart Failure
    Smrithi Sukumar, Jason H. Wasfy, James L. Januzzi, Jeffrey M. Peppercorn, Fumiko Ladd Chino, Haider Javed Warraich · 2023 · Journal of the American College of Cardiology
  3. Reverse Cardiac Remodeling and Outcome After Initiation of Sacubitril/Valsartan
    James L. Januzzi, Alexander Camacho, Ileana L. Piña, Ricardo Rocha, KRISTIN M. WILLIAMSON, Alan S. Maisel, Gary Michael Felker, MARGARET FORNEY PRESCOTT, Javed Butler, Scott David Solomon et al. · 2020 · Circulation Heart Failure
  4. Telehealth Is Having a Moment
    Athena Poppas, John S. Rumsfeld, Jeffrey D. Wessler · 2020 · Journal of the American College of Cardiology
  5. Use of Hydralazine‐Isosorbide Dinitrate Combination in African American and Other Race/Ethnic Group Patients With Heart Failure and Reduced Left Ventricular Ejection Fraction
    Harsh B. Golwala, Udho Thadani, Li Liang, Stavros Stavrakis, Javed Butler, Clyde W. Yancy, Deepak L. Bhatt, Adrian F. Hernandez, Gregg C. Fonarow · 2013 · Journal of the American Heart Association
  6. Clinical Effectiveness of Hydralazine–Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Get With The Guidelines-Heart Failure Registry
    Prateeti Khazanie, Li Liang, Lesley H. Curtis, Javed Butler, Zubin J. Eapen, Paul A. Heidenreich, Deepak L. Bhatt, Eric David Peterson, Clyde W. Yancy, Gregg C. Fonarow et al. · 2016 · Circulation Heart Failure
  7. Influenza vaccination: a one-shot deal to reduce cardiovascular events
    Orly Vardeny, Scott David Solomon · 2016 · European Heart Journal
  8. Cost‐Effectiveness of Ivabradine for Heart Failure in the United States
    Anuraag R. Kansal, Martín Cowie, Adrian Kielhorn, Stanimira Krotneva, Ali Tafazzoli, Ying Zheng, Nicole Yurgin · 2016 · Journal of the American Heart Association
  9. The effects of erythropoiesis stimulating therapy for anemia in chronic heart failure: A meta-analysis of randomized clinical trials
    Jeehoon Kang, Jonghanne Park, Joo Myung Lee, Jin Joo Park, Dong‐Ju Choi · 2016 · International Journal of Cardiology
  10. Outcomes of a Pharmacist-Managed Heart Failure Medication Titration Assistance Clinic
    Shubha Bhat, Mayank Mohan Kansal, George T. Kondos, Vicki L. Groo · 2018 · Annals of Pharmacotherapy
  11. Improving medication titration in heart failure by embedding a structured medication titration plan
    Annabel Hickey, Jessica M. Suna, Louise Marquart, Charles P. Denaro, George Javorsky, Andrew Munns, Alison Mudge, John James Atherton · 2016 · International Journal of Cardiology
  12. The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study
    Nasrien E. Ibrahim, James L. Januzzi · 2018 · Current Heart Failure Reports
  13. Consultation with cardiologists for persons with new-onset chronic heart failure: A population-based study
    Debbie Ehrmann Feldman, Yongling Xiao, Sasha Bernatsky, Jeannie L Haggerty, Karen Leffondré, Pierre Tousignant, Yves Roy, Michał Abrahamowicz · 2009 · Canadian Journal of Cardiology
  14. Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective
    Adnan Alsumali, Laurence M. Djatche, Andrew H. Briggs, Rongzhe Liu, Ibrahim Diakite, Dipen A. Patel, Yufei Wang, Dominik Lautsch · 2021 · PharmacoEconomics
  15. Practical Considerations for the Use of Sodium-Glucose Co-Transporter 2 Inhibitors in Heart Failure
    Michael C. Honigberg, Orly Vardeny, Muthiah Vaduganathan · 2020 · Circulation Heart Failure
  16. Variability in Retail Pricing of Generic Drugs for Heart Failure
    Paul J. Hauptman, Zackary D. Goff, Andrija Vidic, John T. Chibnall, Barry E. Bleske · 2016 · JAMA Internal Medicine
  17. Higher Risk for Incident Heart Failure and Cardiovascular Mortality Among Community-Dwelling Octogenarians Without Pneumococcal Vaccination
    Momanna B. Ahmed, Kanan Patel, Gregg C. Fonarow, Charity Johanna Morgan, Javed Butler, Vera Bittner, Andrzej Kulczycki, Raya Kheirbek, Wilbert S. Aronow, Ross D. Fletcher et al. · 2015 · ESC Heart Failure
  18. Team-based Care for Advanced Heart Failure
    Omar Wever‐Pinzon, Stavros George Drakos, James C. Fang · 2015 · Heart Failure Clinics
  19. A qualitative secondary data analysis of intentional and unintentional medication nonadherence in adults with chronic heart failure
    Barbara J. Riegel, Victoria Vaughan Dickson · 2016 · Heart & Lung
  20. Sacubitril-Valsartan for the Treatment of Heart Failure
    Daniel A. Ollendorf, Alexander T. Sandhu, Steven D. Pearson · 2015 · JAMA Internal Medicine
  21. Rationale and design of a navigator‐driven remote optimization of guideline‐directed medical therapy in patients with heart failure with reduced ejection fraction
    Alexander J. Blood, Christina M. Fischer, Liliana E. Fera, Taylor E. MacLean, Katelyn V. Smith, Jacqueline R. Dunning, Joshua W. Bosque-Hamilton, Samuel Aronson, Thomas Andrew Gaziano, Calum A. MacRae et al. · 2019 · Clinical Cardiology
  22. Background Medical Therapy and Clinical Outcomes From the VICTORIA Trial
    Justin Adrian Ezekowitz, Ciaran J. McMullan, Cynthia M. Westerhout, Ileana L. Piña, Jose Luis Lopez-Sendon, Kevin Joseph Anstrom, Adrian F. Hernandez, Carolyn S.P. Lam, Christopher M. O’Connor, Burkert Mathias Pieske et al. · 2023 · Circulation Heart Failure
  23. Sustained Reduction in Pulmonary Artery Pressures and Hospitalizations During 2 Years of Ambulatory Monitoring
    James Thomas Heywood, SANDIP K. ZALAWADIYA, Robert C. Bourge, Maria Rosa Costanzo, Akshay Suvas Desai, Lisa D. Rathman, NIRAV Y. RAVAL, David M. Shavelle, John Henderson, Marie‐Elena Brett et al. · 2022 · Journal of Cardiac Failure
  24. Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America
    Ankeet S. Bhatt, ERIC D. ADLER, Nancy M. Albert, Anelechi Anyanwu, Nahid Bhadelia, Leslie T. Cooper, Ashish Adrian Correa, Ersilia M. DeFilippis, Emer Joyce, Andrew J. Sauer et al. · 2021 · Journal of Cardiac Failure
  25. Patient Selection for Advanced Heart Failure Therapy Referral
    Alexander C. Fanaroff, Adam D. DeVore, Robert John Mentz, Mani Ali Daneshmand, Chetan B. Patel · 2014 · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine
  26. Comprehensive Discharge Planning With Postdischarge Support for Older Patients With Congestive Heart Failure: A Meta-analysis
    Phillips, Christopher O., Wright, Scott M., Kern, David E., Singa, Ramesh M., Shepperd, Sasha, Rubin, Haya R. · 2004 · JAMA
  27. Prediction of Left Ventricular Ejection Fraction Change Following Treatment With Sacubitril/Valsartan
    Reza Mohebi, Yuxi Liu, Gary Michael Felker, MARGARET FORNEY PRESCOTT, Ileana L. Piña, Javed Butler, Jonathan H. Ward, Scott David Solomon, James L. Januzzi · 2022 · JACC Heart Failure
  28. The role of a multidisciplinary heart failure clinic in optimization of guideline-directed medical therapy: HF-optimize
    Theresa Diederich, Adam F. Burdorf, Bunny Pozehl, Stephanie Bowman, Kelly K. Ferguson, Kyana Holder, Windy Alonso, Douglas A. Stoller, Scott W. Lundgren · 2022 · Heart & Lung
  29. Smartphone-Based Remote Monitoring for Chronic Heart Failure: Mixed Methods Analysis of User Experience From Patient and Nurse Perspectives
    Alice Auton, Sameer Uz Zaman, Yorissa Padayachee, Jack Samways, Nicholas M. Quaife, Mark Sweeney, Indira Tenorio, Nick Linton, Graham D. Cole, Nicholas Simon Peters et al. · 2023 · JMIR Nursing
  30. A Heart Failure Initiative to Reduce the Length of Stay and Readmission Rates
    Sabrina M White, Alethea N. Hill · 2014 · Professional Case Management
  31. Influenza vaccination in patients with chronic heart failure: The PARADIGM-HF trial
    Orly Vardeny, Brian Lee Claggett, Jacob Allen Udell, Milton Packer, Michael R. Zile, Jean Lucien Rouleau, Karl B Swedberg, Desai, Akshay S., Martin P. Lefkowitz, Victor Chengwei Shi et al. · 2016 · Research Bank (Australian Catholic University)
  32. Cost effectiveness analyses of pharmacological treatments in heart failure
    Audrey Huili Lim, Nusaibah Abdul Rahim, Jinxin Zhao, S. Y. Amy Cheung, Yu‐Wei Lin · 2022 · Frontiers in Pharmacology
  33. Home-Based Cardiac Rehabilitation Among Patients Unwilling to Participate in Hospital-Based Programs
    Irene Nabutovsky, Daniel Breitner, Alexis Heller, Yoav Levine, Merav Moreno, Mickey Scheinowitz, Chedva Levin, Robert Klempfner · 2023 · Journal of Cardiopulmonary Rehabilitation and Prevention
  34. Development of an algorithm to detect and reduce complexity of drug treatment and its technical realisation
    Viktoria Sophie Wurmbach, Steffen J. Schmidt, Anette Lampert, Eduard Frick, Michael Metzner, Simone Bernard, Petra Thürmann, Stefan Wilm, Achim Mortsiefer, Attila Altiner et al. · 2020 · BMC Medical Informatics and Decision Making
  35. Impact of a Medication Optimization Clinic on Heart Failure Hospitalizations
    James C. Coons, Jennifer Kliner, Michael A. Mathier, Suresh R Mulukutla, Floyd W. Thoma, Ahmet Sezer, Chad Beisel, Taylor Glassbrenner, Mary Keebler · 2022 · The American Journal of Cardiology
  36. Nurse-Led Titration of Angiotensin-Converting Enzyme Inhibitors, β-Adrenergic Blocking Agents, and Angiotensin Receptor Blockers in Patients With Heart Failure With Reduced Ejection Fraction
    Andrea Driscoll, Judy Currey, Andrew Maxwell Tonkin · 2016 · JAMA Cardiology
  37. Time to Quadruple Guideline-Directed Medical Therapy as a Key Performance Measure for Heart Failure
    Izza Shahid, Gregg C. Fonarow, Stephen John Greene · 2023 · Journal of Cardiac Failure
  38. Effects of sacubitril/valsartan on exercise capacity: a prognostic improvement that starts during uptitration
    Massimo Mapelli, Irene Mattavelli, Stefania Paolillo, Elisabetta Salvioni, Damiano Magrì, Arianna Galotta, Fabiana De Martino, Valentina Mantegazza, Carlo Vignati, Immacolata Esposito et al. · 2023 · European Journal of Clinical Pharmacology
  39. Team-Based Care for Managing Noncardiac Conditions in Patients with Heart Failure
    Justin M. Vader, Michael W. Rich · 2015 · Heart Failure Clinics
  40. Efficacy and safety of sacubitril valsartan in heart failure compared to renin angiotensin aldosterone system inhibitors: a systematic review and meta analysis of randomised controlled trials
    Amanda Hernandez, Vinay Pasupuleti, Nancy Scarpelli, Jack E. Malespini, Maciej Banach, Agata Magdalena Bielecka-Dabrowa · 2022 · European Heart Journal
  41. Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP‐HF
    Brittany Chapman, Anne S. Hellkamp, Laine Elliott Thomas, Nancy M. Albert, Javed Butler, James Herbert Patterson, Adrian F. Hernandez, Fredonia B. Williams, Xian Shen, John A. Spertus et al. · 2022 · Journal of the American Heart Association
  42. Impact of a Telemedicine Program After a Heart Failure Hospitalization on 12 Months Follow-Up Events
    María Inés Sosa Liprandi, Melisa Elfman, Ezequiel José Zaidel, Matías Viniegra, Álvaro Sosa Liprandi · 2023 · Current Problems in Cardiology
  43. The Implementation of a Patient Assistance Program in a Free Clinic Setting: A Case Report
    Erin B. Clarkson, Alexandra Linley, Jennifer Sandson, Cynthia S. Selleck · 2016 · Journal of Health Care for the Poor and Underserved
  44. The effectiveness of group visits for patients with heart failure on knowledge, quality of life, self-care, and readmissions: a systematic review protocol
    Jason T. Slyer, Lucille R. Ferrara · 2012 · The JBI Database of Systematic Reviews and Implementation Reports
  45. Heart Failure Phenotypes According to Natriuretic Peptide Trajectory Following Initiation of Sacubitril/Valsartan
    Reza Mohebi, Yuxi Liu, Peder Langeland Myhre, Gary Michael Felker, MARGARET FORNEY PRESCOTT, Ileana L. Piña, Javed Butler, Jonathan H. Ward, Scott David Solomon, James L. Januzzi · 2023 · JACC Heart Failure
  46. Influence of Diuretic Dose and Route of Administration on Loop Diuretic Efficiency: Insights from the Diuretic Optimization Strategies Evaluation in Acute Heart Failure (DOSE-AHF) Trial
    Jeffrey Moore Testani, Susanna R. Stevens, Meredith Ann Brisco, Adrian F. Hernandez, Kevin Joseph Anstrom, W.H. Wilson Tang · 2014 · Journal of Cardiac Failure
  47. Comparison of Angioedema in Heart Failure Patients Treated with Sacubitril/Valsartan or Enalapril in the PARADIGM-HF Study
    Alan Kaplan, Henk Johan Streefkerk, Christine Thorburn, Victor Chengwei Shi, Wenchun Zhou, Heike Schwende, Milton Packer · 2016 · Journal of Cardiac Failure
  48. Navigator-Driven Remote Optimization of Guideline-Directed Medical Therapy in Patients with Heart Failure with Reduced Ejection Fraction: Program Design and Initial feasibility
    Liliana E. Fera, Taylor E. MacLean, Christina M. Fischer, Katelyn V. Smith, Jacqueline R. Dunning, Joshua W. Bosque-Hamilton, Samuel Aronson, Thomas Andrew Gaziano, Calum A. MacRae, Lina S. Matta et al. · 2018 · Journal of Cardiac Failure
  49. Best Practice: Using Pharmacist- and Nurse-Led Optimization in Heart Failure to Achieve Guideline-directed Medical Therapy Goals
    Craig James Beavers, Corrine Y. Jurgens · 2023 · Journal of Cardiac Failure
  50. Using Sacubitril/Valsartan to Decrease Health care Costs in Population Health Patients
    Nihanth Damera, Chirag Dipak Shah, Bistees George, Jeffrey J. Chapa, Ed Lee, Richard Bernhardt, Lindsey J. Reese, Roopa Akkadka Rao · 2023 · The American Journal of Cardiology